A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): A pilot study

European Journal of Nutrition

Volumn 52, Issue 2, 2013, Pages 527-535

  Volynets, Valentina ^a   Machann, Jürgen ^b   Küper, Markus A ^b   Maier, Ina B ^a   Spruss, Astrid ^a   Königsrainer, Alfred ^b   Bischoff, Stephan C ^a   Bergheim, Ina ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Endotoxin; Fructose; Metabolic syndrome; NAFLD; PAI 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY FAT DISTRIBUTION; BODY MASS; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FAT CONTENT; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INTERVENTION STUDY; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSIT TIME; MALE; METABOLIC PARAMETERS; NONALCOHOLIC FATTY LIVER; NUTRITIONAL ASSESSMENT; PILOT STUDY; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; ENERGY INTAKE; ETHANOL; FATTY LIVER; FEMALE; FOOD HABITS; FRUCTOSE; HUMANS; INSULIN; INTERVENTION STUDIES; INTRA-ABDOMINAL FAT; LIPIDS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR ACTIVITY; PILOT PROJECTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSAMINASES; WEIGHT LOSS;

BACTERIA (MICROORGANISMS);

EID: 84877021427     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-012-0355-z     Document Type: Article

References (31)

1. Thuy S, Ladurner R, Volynets V, Wagner S, Stahl S, Königsrainer A, et al. (2008) Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 138:1452-1455
2. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48:206-211
3. Soza A, Riquelme A, Gonzalez R, Alvarez M, Perez-Ayuso RM, Glasinovic JC, et al. (2005) Increased orocecal transit time in patients with nonalcoholic fatty liver disease. Dig Dis Sci 50:1136-1140
4. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al. (2009) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49:1877-1887
5. Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM, et al. (2008) Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int 28:1026-1033
6. Nair S, Cope K, Risby TH, Diehl AM (2001) Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 96:1200-1204
7. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, et al. (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48:993-999
8. Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, et al. (2008) Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 22:811-816
9. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, et al. (2010) Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51:1961-1971
10. Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, et al. (2005) Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 45:1012-1018
11. Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, et al. (2008) Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48:983-992
12. Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, Bergheim I (2010) Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am J Physiol Gastrointest Liver Physiol 298:G335-G344
13. Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I (2011) Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1 (PAI-1), microsomal triglyceride transfer protein (MTTP) and NKT cells. Lab Invest 91:885-895
14. Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I (2009) Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50:1094-1104
15. Volynets V, Spruss A, Kanuri G, Wagnerberger S, Bischoff SC, Bergheim I (2010) Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice. J Lipid Res 51:3414-3424
16. Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, Claussen CD, et al. (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21:455-462
17. Machann J, Thamer C, Schnoedt B, Stefan N, Haring HU, Claussen CD, et al. (2006) Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 55:913-917
18. Landig J, Erhardt JG, Bode JC, Bode C (1998) Validation and comparison of two computerized methods of obtaining a diet history. Clin Nutr 17:113-117
19. Generoso M, De Rosa M, De Rosa R, De Magistris L, Secondulfo M, Fiandra R, et al. (2003) Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci 783:349-357
20. Cariello R, Federico A, Sapone A, Tuccillo C, Scialdone VR, Tiso A, et al. (2010) Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis 42:200-204
21. Bonnichsen RK, Theorell H (1951) An enzymatic method for the microdetermination of ethanol. Scand J Clin Lab Invest 3:58-62
22. Parlesak A, Klein B, Schecher K, Bode JC, Bode C (2003) Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc 51:768-773
23. La Brooy SJ, Male PJ, Beavis AK, Misiewicz JJ (1983) Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time. Gut 24:893-896
24. York LW, Puthalapattu S, Wu GY (2009) Nonalcoholic fatty liver disease and low-carbohydrate diets. Annu Rev Nutr 29:365-379
25. Centis E, Marzocchi R, Di Domizio S, Ciaravella MF, Marchesini G (2010) The effect of lifestyle changes in non-alcoholic fatty liver disease. Dig Dis Sci 28:267-273
26. Thoma C, Day CP, Trenell MI (2011) Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepat. doi: 10.1016j.jhep.2011.06.010
27. Parlesak A, Bode JC, Bode C (1994) Parallel determination of gut permeability in man with M(r) 400, M(r) 1500, M(r) 4000 and M(r) 10,000 polyethylene glycol. Eur J Clin Chem Clin Biochem 32:813-820
28. Baffy G (2009) Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51:212-223
29. Golay A, Eigenheer C, Morel Y, Kujawski P, Lehmann T, de Tonnac C (1996) Weight-loss with low or high carbohydrate diet? Int J Obes Relat Metab Disord 20:1067-1072
30. Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, et al. (2005) One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 100:1072-1081
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419